{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:41Z","timestamp":1793395001363,"version":"4.5.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"DOI":"10.1093\/hmg\/ddr541","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T20:44:01Z","timestamp":1321562641000},"page":"1124-1137","source":"Crossref","is-referenced-by-count":152,"title":["Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease"],"prefix":"10.1093","volume":"21","author":[{"given":"Ashu","family":"Johri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel Y.","family":"Calingasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Hennessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"key\n\t\t\t\t20170522145342_DDR541C1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522145342_DDR541C3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1\u03b1 null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522145342_DDR541C4","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1\u03b1 deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522145342_DDR541C6","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal"},{"key":"key\n\t\t\t\t20170522145342_DDR541C7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2032dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522145342_DDR541C8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522145342_DDR541C9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"key\n\t\t\t\t20170522145342_DDR541C10","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1\u03b1 function in muscle in Huntington's disease","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522145342_DDR541C11","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522145342_DDR541C12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature00904","article-title":"Transcriptional co-activator PGC-1\u03b1 drives the formation of slow-twitch muscle fibres","volume":"418","author":"Lin","year":"2002","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522145342_DDR541C13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20754","article-title":"Low stability of Huntington muscle mitochondria against Ca2+ in R6\/2 mice","volume":"59","author":"Gizatullina","year":"2006","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/mds.21550","article-title":"Myopathy as a first symptom of Huntington's disease in a Marathon runner","volume":"22","author":"Kosinski","year":"2007","journal-title":"Mov. Disord."},{"key":"key\n\t\t\t\t20170522145342_DDR541C15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/mds.21540","article-title":"Clinical correlates of mitochondrial function in Huntington's disease muscle","volume":"22","author":"Turner","year":"2007","journal-title":"Mov. Disord."},{"key":"key\n\t\t\t\t20170522145342_DDR541C16","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522145342_DDR541C17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-4-3","article-title":"The gene coding for PGC-1\u03b1 modifies age at onset in Huntington's disease","volume":"4","author":"Weydt","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"key\n\t\t\t\t20170522145342_DDR541C18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-4-10","article-title":"PGC-1alpha as modifier of onset age in Huntington disease","volume":"4","author":"Taherzadeh-Fard","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"key\n\t\t\t\t20170522145342_DDR541C19","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522145342_DDR541C20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models","volume":"18","author":"Phan","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522145342_DDR541C21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","article-title":"Activation of the PPAR\/PGC-1\u03b1 pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype","volume":"8","author":"Wenz","year":"2008","journal-title":"Cell Metab."},{"key":"key\n\t\t\t\t20170522145342_DDR541C22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2840-4-14","article-title":"Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons","volume":"4","author":"Tenenbaum","year":"2005","journal-title":"Cardiovasc. Diabetol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C23","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/jc.2007-1701","article-title":"Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients cells lacking its components","volume":"93","author":"Bastin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170522145342_DDR541C24","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1210\/en.2006-0070","article-title":"Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1\u03b1 gene transcription: an autoregulatory loop controls PGC-1\u03b1 expression in adipocytes via peroxisome proliferator-activated receptor-\u03b3 coactivation","volume":"147","author":"Hondares","year":"2006","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170522145342_DDR541C25","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/j.1582-4934.2010.01223.x","article-title":"A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations","volume":"15","author":"Wenz","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"key\n\t\t\t\t20170522145342_DDR541C26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.RES.0000141774.29937.e3","article-title":"Nuclear receptor signaling and cardiac energetics","volume":"95","author":"Huss","year":"2004","journal-title":"Circ. Res."},{"key":"key\n\t\t\t\t20170522145342_DDR541C27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab."},{"key":"key\n\t\t\t\t20170522145342_DDR541C28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170522145342_DDR541C29","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C30","first-page":"218","article-title":"Phenotypic characterization of genetically engineered mice","volume-title":"Handbook of Laboratory Animal Science: Essential Principles and Practices","author":"Rubin","year":"2003","edition":"2nd edn"},{"key":"key\n\t\t\t\t20170522145342_DDR541C31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522145342_DDR541C32","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosome neurons in Huntington's disease","volume":"54","author":"Hedreen","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1427.008","article-title":"Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants","volume":"1147","author":"Stack","year":"2008","journal-title":"Ann. NY Acad. Sci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"key":"key\n\t\t\t\t20170522145342_DDR541C37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522145342_DDR541C38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"key\n\t\t\t\t20170522145342_DDR541C39","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C40","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522145342_DDR541C41","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1\u03b1 contributes to dysmyelination in experimental models of Huntington's disease","volume":"31","author":"Xiang","year":"2011","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1471-4159.2003.02195.x","article-title":"Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice","volume":"88","author":"Hinerfeld","year":"2004","journal-title":"J. Neurochem."},{"key":"key\n\t\t\t\t20170522145342_DDR541C43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmet.2011.04.011","article-title":"In vivo correction of COX deficiency by activation of the AMPK\/PGC-1\u03b1 axis","volume":"14","author":"Viscomi","year":"2011","journal-title":"Cell Metab."},{"key":"key\n\t\t\t\t20170522145342_DDR541C44","article-title":"Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice","author":"Yatsuga","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522145342_DDR541C45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1602\/neurorx.1.3.298","article-title":"Translating therapies for Huntington's disease from genetic animal models to clinical trials","volume":"1","author":"Hersch","year":"2004","journal-title":"NeuroRx"},{"key":"key\n\t\t\t\t20170522145342_DDR541C46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170522145342_DDR541C47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington's disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C48","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"key\n\t\t\t\t20170522145342_DDR541C50","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522145342_DDR541C51","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","article-title":"Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease","volume":"283","author":"Quintanilla","year":"2008","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522145342_DDR541C52","doi-asserted-by":"crossref","first-page":"21379","DOI":"10.1074\/jbc.M109.018911","article-title":"PGC-1\u03b1 and PGC-1\u03b2 regulate mitochondrial density in neurons","volume":"284","author":"Wareski","year":"2009","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522145342_DDR541C53","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522145342_DDR541C54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease","volume":"225","author":"Ho","year":"2010","journal-title":"Exp. Neurol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bss0660043","article-title":"Mitochondria, NO and neurodegeneration","volume":"66","author":"Beal","year":"1999","journal-title":"Biochem. Soc. Symp."},{"key":"key\n\t\t\t\t20170522145342_DDR541C56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","article-title":"Oxidative stress in Huntington's disease","volume":"9","author":"Browne","year":"1999","journal-title":"Brain Pathol."},{"key":"key\n\t\t\t\t20170522145342_DDR541C57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"key":"key\n\t\t\t\t20170522145342_DDR541C58","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522145342_DDR541C59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000327910","article-title":"Truncated peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 splice variant is severely altered in Huntington's disease","volume":"8","author":"Johri","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"key\n\t\t\t\t20170522145342_DDR541C60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1570-0232(02)00273-8","article-title":"Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples","volume":"775","author":"Agarwal","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/21\/5\/1124\/17258641\/ddr541.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T15:21:05Z","timestamp":1560957665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddr541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,11,17]]},"published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddr541","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13493959.14872058","asserted-by":"object"}]},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}